Drug Shortage Report for MAR-METHIMAZOLE
Report ID | 70241 |
Drug Identification Number | 02480107 |
Brand name | MAR-METHIMAZOLE |
Common or Proper name | MAR-METHIMAZOLE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | THIAMAZOLE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 Tablet |
ATC code | H03BB |
ATC description | ANTITHYROID PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-18 |
Actual start date | 2018-12-18 |
Estimated end date | 2019-01-10 |
Actual end date | 2019-01-06 |
Shortage status | Resolved |
Updated date | 2019-01-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-01-08 | French | Compare |
v3 | 2019-01-08 | English | Compare |
v2 | 2018-12-20 | French | Compare |
v1 | 2018-12-20 | English | Compare |
Showing 1 to 4 of 4